The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan
The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
This analysis estimates the economic and clinical impact of a Moderna updated COVID-19 mRNA Fall 2023 vaccine for adults ≥18 years in Japan. A previously developed Susceptible-Exposed-Infected-Recovered (SEIR) model with a one-year analytic time horizon (September 2023–August 2024) and consequences decision tree were used to estimate symptomatic in...
Alternative Titles
Full title
The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_da76065fc17949a49012cbcbf689d9e4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da76065fc17949a49012cbcbf689d9e4
Other Identifiers
ISSN
2076-393X
E-ISSN
2076-393X
DOI
10.3390/vaccines12040434
